C07C 50/02
Quinones: with monocyclic quinoid structure
Official title: with monocyclic quinoid structure
C07C50/02 (Quinones: with monocyclic quinoid structure) appears on 72 US grants and 60 published applications in this corpus.
Search patents in C07C- Granted patents
- 72
- Published applications
- 60
- Assignees
- 72
- Inventors
- 186
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 1 | 5 |
| 2008 | 2 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 1 | 3 |
| 2013 | 1 | 3 |
| 2014 | 3 | 3 |
| 2015 | 3 | 1 |
| 2016 | 5 | 3 |
| 2017 | 2 | 3 |
| 2018 | 3 | 3 |
| 2019 | 3 | 2 |
| 2020 | 3 | 2 |
| 2021 | 4 | 6 |
| 2022 | 2 | 5 |
| 2023 | 4 | 7 |
| 2024 | 2 | 3 |
| 2025 | 3 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Electroactive species and method for electrochemical gas separation4 Nov 2025US 12,458,922 B2Verdox, Inc.
- Iron catalyzed highly enantioselective cis-dihydroxylation of quinones22 Apr 2025US 12,281,065 B2Laboratory for Synthetic Chemistry and Chemical Biology Limited
- Nanomaterial, preparation method thereof, and semiconductor device18 Feb 2025US 12,232,339 B2Tcl Technology Group Corporation
- Non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery including the same24 Sep 2024US 12,100,806 B2LG Energy Solution, Ltd.
- Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia16 Jul 2024US 12,037,350 B2Stealth BioTherapeutics Inc.
- Quinone-derived compounds and use thereof against leishmania spp22 Jan 2026US 2026/0022089 A1Universidad De La Laguna
- Processes for the Production of Vanillin and Related Compounds28 Aug 2025US 2025/0270160 A1Univerza v Ljubljani
- Method for storing reduced coenzyme q1013 Mar 2025US 2025/0082585 A1Kaneka Corporation
- Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia5 Dec 2024US 2024/0400588 A1Stealth BioTherapeutics Inc.
- Process for preparing acyl derivatives17 Oct 2024US 2024/0343680 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers49US 7,432,305 B2Edison Pharmaceuticals, Inc. · 2008
- Treatment of pervasive developmental disorders with redox-active therapeutics47US 8,314,153 B2Edison Pharmaceuticals, Inc. · 2012
- Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures40US 7,345,301 B2Merck Patent GmbH · 2008
- Quinone compounds and their use in suppressing the production of SRS-A in mammals39US 4,393,075 ATakeda Chemical Industries, Ltd. · 1983
- 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases36US 8,716,486 B2Edison Pharmaceuticals, Inc. · 2014